(Q67897406)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1824907%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

title

Clinical safety and efficacy of celiprolol (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1824907%20AND%20SRC:MED&resulttype=core&format=json

Cardiology and cardiovascular medicine

18 September 2019

main subject

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

3 December 2022

author name string

K. D. Lamon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1824907

3 December 2022

language of work or name

English

0 references

publication date

1 February 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1824907%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

18 September 2019

https://api.elsevier.com/content/article/PII:000287039190446O?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

https://api.elsevier.com/content/article/PII:000287039190446O?httpAccept=text/plain

3 December 2022

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

3 December 2022

published in

American Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1824907%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

volume

121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1824907%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

issue

2 Pt 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1824907%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

page(s)

683-687

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1824907%20AND%20SRC:MED&resulttype=core&format=json

Celiprolol in systemic hypertension

18 September 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

A comparison of celiprolol and propranolol in the treatment of hypertension in one hundred and seventy-nine subjects

3 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

Evaluation of the antihypertensive effect of celiprolol by ambulatory blood pressure monitoring

3 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris

3 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

Qualities of an ideal beta-adrenoceptor antagonist and comparison of existing agents with a new cardioselective hydrophilic vasodilator beta-adrenoceptor antagonist, celiprolol

3 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity

3 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

Beta-adrenergic blockade. An update

3 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

Acute hemodynamic effects of celiprolol

3 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

The central and peripheral hemodynamics of celiprolol

3 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

Improved left ventricular function during exercise: a comparison of celiprolol and atenolol

3 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

Systemic and regional haemodynamic profile of diuretics and alpha- and beta-blockers. A review comparing acute and chronic effects

3 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

Celiprolol--review of airways studies

3 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

Results of the Austrian celiprolol postmarketing surveillance study

3 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension

3 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

Celiprolol in the treatment of hypertension: a comparison with propranolol

3 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

A randomized double-blind study of atenolol and celiprolol in mild to moderate hypertension

3 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

A comparison of celiprolol and atenolol in the treatment of hypertension

3 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

Celiprolol and verapamil in the treatment of essential hypertension

3 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

Effects of celiprolol on systemic and forearm circulation in hypertensive patients: a double-blind cross-over study versus metoprolol

3 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

Safety profile of celiprolol

3 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

Reduction of left ventricular hypertrophy in hypertensive patients after treatment with celiprolol

3 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

A long-term study of the effects of celiprolol on blood pressure and lipid-associated risk factors.

3 December 2022

27

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol

3 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90446-O

3 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1824907%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference